PT Medikaloka Hermina TbkISX:HEAL -0.59%72 Dividend Yield % is 1.60% as of Jul. 02, 2026, which is 256% above its 10-year median of 0.45. GuruFocus rates ISX:HEAL with a GF Score™ of 72/100 and a GF Value™ of Rp1,577.62 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 282 Healthcare Providers & Services companies, PT Medikaloka Hermina Tbk ranks worse than 64.89% on this metric.
PT Medikaloka Hermina Tbk stock Dividend Yield % is close to 10-year high.
The historical rank and industry rank for PT Medikaloka Hermina Tbk's Dividend Yield % or its related term are showing as below:
ISX:HEAL'
s Dividend Yield % Range Over the Past 10 Years
Min: 0.24 Med: 0.45 Max: 1.66
Current: 1.6
During the past 11 years, the highest Dividend Yield of PT Medikaloka Hermina Tbk was 1.66%. The lowest was 0.24%. And the median was 0.45%.
ISX:HEAL's Dividend Yield % is ranked worse than 64.89% of 282
companies
in the Healthcare Providers & Services industry
Industry Median: 2.365
vs ISX:HEAL: 1.60
During the past 12 months, PT Medikaloka Hermina Tbk's average Dividends Per Share Growth Rate was 23.50% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 20.50% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 29.80% per year.
During the past 11 years, the highest 3-Year average Dividends Per Share Growth Rate of PT Medikaloka Hermina Tbk was 42.90% per year. The lowest was 19.30% per year. And the median was 30.10% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ISX:HEAL vs HCA, THC, DVA: Dividend Yield % Comparison
For the Medical Care Facilities subindustry, PT Medikaloka Hermina Tbk's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Medikaloka Hermina Tbk Dividend Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PT Medikaloka Hermina Tbk's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where PT Medikaloka Hermina Tbk's Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
PT Medikaloka Hermina Tbk Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
IDR 13.500000
2026-05-05
2026-05-06
2026-05-22
Cash Dividend
annually
IDR:IDR 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Medikaloka Hermina Tbk (ISX:HEAL) has a Dividend Yield % of 1.60% as of Jul. 02, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on PT Medikaloka Hermina Tbk and its competitors. This is 256% above median its historical median of 0.45. Over the past decade, PT Medikaloka Hermina Tbk's Dividend Yield % has ranged from 0.24 to 1.66. According to the industry distribution chart, PT Medikaloka Hermina Tbk ranks #183 out of 282 companies in the Healthcare Providers & Services industry, placing it in the top 64.9%.
Is PT Medikaloka Hermina Tbk's Dividend Yield % too high?
PT Medikaloka Hermina Tbk's current Dividend Yield % of 1.60% is 256% above median its 10-year median of 0.45. Over the past 10 years, this metric has ranged from a low of 0.24 to a high of 1.66. The Healthcare Providers & Services industry median Dividend Yield % is 2.37. PT Medikaloka Hermina Tbk's value of 1.60% is 32.3% below this industry median. Based on the distribution chart, PT Medikaloka Hermina Tbk ranks #183 out of 282 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, PT Medikaloka Hermina Tbk has a GF Score™ of 72/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Medikaloka Hermina Tbk's Dividend Yield % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, PT Medikaloka Hermina Tbk ranks #183 out of 282 companies for Dividend Yield %. This places PT Medikaloka Hermina Tbk in the lower half of its industry. The industry median Dividend Yield % is 2.37. PT Medikaloka Hermina Tbk's value of 1.60% is 32.3% below this benchmark. Historically, PT Medikaloka Hermina Tbk's own Dividend Yield % has ranged from 0.24 to 1.66 over the past decade. While the company's 10-year median is 0.45 vs. the industry median of 2.37, PT Medikaloka Hermina Tbk has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Healthcare Providers & Services company?
The median Dividend Yield % among Healthcare Providers & Services companies is 2.37, based on 282 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Medikaloka Hermina Tbk's current Dividend Yield % of 1.60% is 32.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on PT Medikaloka Hermina Tbk and its competitors. For the Healthcare Providers & Services industry, the median Dividend Yield % is 2.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Medikaloka Hermina Tbk's current Dividend Yield % is 1.60%, which is 256% above median its own 10-year median of 0.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Medikaloka Hermina Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Medikaloka Hermina Tbk (ISX:HEAL) is currently considered Significantly Undervalued. The stock's GF Value™ is Rp1,577.62, compared to a current price of Rp840.00 — trading 46.8% below its estimated fair value. The current Dividend Yield % is 1.60%, which is 256% above median its 10-year median of 0.45 and 32.3% below the Healthcare Providers & Services industry median of 2.37. PT Medikaloka Hermina Tbk's overall GF Score™ is 72/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For PT Medikaloka Hermina Tbk (ISX:HEAL), the current Dividend Yield % is 1.60% as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Medikaloka Hermina Tbk (ISX:HEAL) Overvalued in 2026?
Based on GuruFocus' analysis, PT Medikaloka Hermina Tbk stock appears to be undervalued.
The current stock price of Rp840.00 is trading 46.8% below its estimated GF Value™ of Rp1,577.62.
GuruFocus considers PT Medikaloka Hermina Tbk to be Significantly Undervalued.
Key valuation signals for ISX:HEAL:
Dividend Yield %: 1.60% (256% above median its 10-year median of 0.45)
GF Value™: Rp1,577.62 vs. price of Rp840.00 (46.8% below fair value)
Industry Position: 32.3% below the Healthcare Providers & Services median (#183 of 282)
No single metric tells the full story. See the ISX:HEAL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Medikaloka Hermina Tbk is a private hospital group. It provides a range of medical services, including maternal and child health services, complex operating procedures, laboratory services, radiology facilities, and fertility treatments as well as general health services, pharmacies, diagnostic and emergency services. The company's geographical segment includes Kalimantan dan Sulawesi, Jawa, and Sumatera. It derives maximum revenue from the Jawa segment.
72GF Score
Get the complete analysis for ISX:HEAL
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:HEAL has been successfully added to your 
